Medication combination is latest approach to quit smoking
A new study, published in the Jan. 8 2014 issue of the Journal of the American Medical Association, found that when Chantix and Wellbutrin were taken in combination, more quitters didn't take up the habit again. This may be good news for heavy smokers that find it nearly impossible to quit.
Should auld acquaintance be forgot, and never brought to mind? According to Thomas Glynn, a director at the American Cancer Society, New Years Day is the most popular quit day for smokers. To me, I feel the proverbial New Years song may be very close to the truth when it comes to quitting smoking. You try to forget and never bring it back to your mind. Good luck on that. Like the smoke from a cigarette itself, the memories and cravings linger.
Perhaps the French poet and novelist (Orpheus) Jean Cocteau said it best. “If an addict who has been completely cured starts smoking again he no longer experiences the discomfort of his first addiction. There exists, therefore, outside alkaloids and habit, a sense for opium, an intangible habit which lives on, despite the recasting of the organism. The dead drug leaves a ghost behind. At certain hours it haunts the house.” The addiction remains, however the form may change. It is therefore important to find whatever tools you need to kick the habit.
According to this latest study, Chantrix and Wellbutrin when taken together increased the rate of quitting over 12 weeks in comparison to taking Chantrix alone. However, relapse rates after 12 months were similar.
"We believe this evidence strongly supports the idea that varenicline (Chantrix) helps everybody quit," said lead researcher Dr. Jon Ebbert, a professor of medicine at the Mayo Clinic in Rochester, Minn. "But for heavier smokers and more dependent smokers, combination therapy with varenicline plus bupropion (Wellbutrin) will increase quit rates more than varenicline alone."
Therefore he indicated that at Mayo Clinic they would be using combination therapy because the two medications work synergistically but in different ways. The medications have been found to target different areas of the brain and therefore may be crucial in the successful treatment of the nicotine addiction.
During the 12 week study, 315 smokers were given either Chantix and Wellbutrin or Chantix and a placebo. Dr Ebbert discovered that 53 percent of those taking the combination of both drugs had successfully quit smoking after 12 weeks. This was in comparison to 43 percent of those taking Chantix alone. In six months, 37% of individuals with the drug combination remained smoke free, while those who took Chantrix alone, only 28% where still successful quitters.
As time progressed the difference became less and less apparent with 31% in the combination and 25% taking Chantrix alone were still not smoking.